Ferriprotoporphyrin IX · SMALL MOLECULE · Plasmodium falciparum
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Ferriprotoporphyrin IX shows approved-linked disease relevance led by malaria. 5 more disease programs remain visible in the same review block. 7 linked drugs keep the current disease frame grounded. Use malaria as the disease frame, then confirm a stable protein accession before cross-source reuse.
Use malaria as the disease frame, then confirm a stable protein accession before cross-source reuse.
Ferriprotoporphyrin IX shows approved-linked disease relevance led by malaria. 5 more disease programs remain visible in the same review block. 7 linked drugs remain visible in the same block.
Start review with malaria because it currently carries approved-linked support. Linked drugs include ARTEMETHER, ARTENIMOL, CHLOROQUINE PHOSPHATE, HYDROXYCHLOROQUINE SULFATE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyFerriprotoporphyrin IX
Review this target as Ferriprotoporphyrin IX.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Ferriprotoporphyrin IX as ChEMBL target CHEMBL613897. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Ferriprotoporphyrin IX still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need to confirm why malaria is currently framed as approved-linked support. It currently carries 7 linked drugs in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Ferriprotoporphyrin IX |
| Target Type | SMALL MOLECULE |
| Organism | Plasmodium falciparum |
Reviewable protein naming and mapping context for this target snapshot.
Review this target as Ferriprotoporphyrin IX.
Open Targets-ready disease context using the current target-indication evidence contract.
Ferriprotoporphyrin IX shows approved-linked disease relevance led by malaria. 5 more disease programs remain visible in the same review block.
Start review with malaria because it currently carries approved-linked support. Linked drugs include ARTEMETHER, ARTENIMOL, CHLOROQUINE PHOSPHATE, HYDROXYCHLOROQUINE SULFATE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL76 | 4.75 | IC50 | 17900.0 | Approved |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 15 | 0 | — |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 9 | 16 | 4.7 |